HALOTEX Drug Patent Profile
✉ Email this page to a colleague
When do Halotex patents expire, and what generic alternatives are available?
Halotex is a drug marketed by Westwood Squibb and is included in two NDAs.
The generic ingredient in HALOTEX is haloprogin. There is one drug master file entry for this compound. Additional details are available on the haloprogin profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HALOTEX?
- What are the global sales for HALOTEX?
- What is Average Wholesale Price for HALOTEX?
Summary for HALOTEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Patent Applications: | 4,493 |
| DailyMed Link: | HALOTEX at DailyMed |
US Patents and Regulatory Information for HALOTEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Westwood Squibb | HALOTEX | haloprogin | CREAM;TOPICAL | 016942-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Westwood Squibb | HALOTEX | haloprogin | SOLUTION;TOPICAL | 016943-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
